Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate

Journal of Urology

Volumn 145, Issue 5, 1991, Pages 907-923

  Oesterling, J E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adenocarcinoma; Carcinoma; Prostate; Tumor markers

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW;

EID: 0025869392     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)38491-4     Document Type: Review

References (112)

1. A.G. Foti J.F. Fenimore-Cooper H. Herschmann R.R. Malvaez Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase New Engl. J. Med. 297 1977 1357
2. M. Henneberry G. Engel J.T. Grayhack Acid phosphatase Urol. Clin. N. Amer. 6 1979 629
3. J.C. Griffiths Prostate-specific acid phosphatase: re-evaluation of radioimmunoassay in diagnosing prostatic disease Clin. Chem. 26 1980 433
4. A.W. Bruce D.G. Mahan L.D. Sullivan L. Goldenberg The significance of prostatic acid phosphatase in adenocarcinoma of the prostate J. Urol. 125 1981 357
5. P. Vihko O. Lukkarinen M. Konturri R. Vihko Effective ness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy on prostatic carcinoma Cancer Res. 41 1981 1180
6. M.C. Wang L.A. Valenzuela G.P. Murphy T.M. Chu Purification of a human prostate specific antigen Invest. Urol. 17 1979 159
7. T.A. Stamey Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate Monogr. Urol. 10 1989 49
8. M. Hara T. Inorre T. Fukuyama Some physico-chemical characteristics of gamma-seminoprotein, an antigenic component specific for human seminal plasma Jap. J. Legal Med. 25 1971 322
9. T.S. Li C.G. Beling Isolation and characterization of two specific antigens of human seminal plasma Fertil. Steril. 24 1973 134
10. G.F. Sensabaugh Isolation and characterization of a semen-specific protein from human seminal plasma: a potential new marker for semen identification J. Forensic Sci. 23 1978 106
11. H.C.B. Graves G.F. Sensabaugh R.T. Blake Postcoital detection of male-specific semen protein. Application to the investigation of rape New Engl. J. Med. 312 1985 338
12. M.C. Wang L.A. Valenzuela G.P. Murphy T.M. Chu A simplified purification procedure for human prostate antigen Oncology 39 1982 1
13. L.D. Papsidero M.C. Wang L.A. Valenzuela G.P. Murphy T.M. Chu A prostate antigen in sera of prostatic cancer patients Cancer Res. 40 1980 2428
14. M. Kuriyama M.C. Wang L.D. Papsidero C.S. Killian T. Shimano L.A. Valenzuela T. Nishiura G.P. Murphy T.M. Chu Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay Cancer Res. 40 1980 4658
15. M.C. Wang L.D. Papsidero M. Kuriyama L.A. Valenzuela G.P. Murphy T.M. Chu Prostate antigen: a new potential marker for prostatic cancer Prostate 2 1981 89
16. T.M. Chu E. Kawinski N. Hibi G. Croghan J. Wiley C.S. Killian D. Corral Prostate-specific antigenic domain of human prostate-specific antigen identified with monoclonal antibodies J. Urol. 141 1989 152
17. K.W.K. Watt P.J. Lee T. M’Timkulu W.P. Chan R. Loor Human prostate-specific antigen: structural and functional similarity with serine proteases Proc. Natl. Acad. Sci. 83 1986 3166
18. M.C. Wang M. Kuriyama L.D. Papsidero R.M. Loor L.A. Valenzuela G.P. Murphy T.M. Chu Prostate antigen of human cancer patients H. Busch L.C. Yeoman Methods in Cancer Research XIX 1982 Academic Press New York 179 197
19. P.H.J. Riegman R.J. Vlietstra J.A.G.M. van der Körpert J.C. Romijn J. Trapman Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene Biochem. Biophys. Res. Comm. 159 1989 95
20. L.J. Schedlich B.H. Bennetts B.J. Morris Primary structure of a human glandular kallikrein gene DNA 6 1987 429
21. A. Lundwall H. Lilja Molecular cloning of human prostate specific antigen with cDNA FEBS Letters 214 1987 317
22. P.H.J. Riegman P. Klaasen J.A.G.M. van der Körper J.C. Romijn J. Trapman Molecular cloning and characterization of novel prostate antigen with cDNA’s Biochem. Biophys. Res. Comm. 155 1988 181
23. H. Lilja A kallikrein-like serine protease in prostatic fluid leaves the predominant seminal vesicle protein J. Clin. Invest. 76 1985 1899
24. L.D. Papsidero M. Kuriyama M.C. Wang J.S. Horoszewicz S.S. Leong L.A. Valenzuela G.P. Murphy T.M. Chu Prostate antigen: a marker for human prostate epithelial cells J. Natl. Cancer Inst. 66 1981 37
25. M. Nadji S.Z. Tabei A. Castro T.M. Chu G.P. Murphy M.C. Wang A.R. Morales Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms Cancer 48 1981 1229
26. G. Mancini O. Carbonara J.F. Heremans Immunochemical quantitation of antigens by single radioimmunodiffusion Immunochemistry 2 1965 235
27. H. Lilja C.B. Laurell The predominant protein in human seminal coagulate Scand. J. Clin. Lab. Invest. 45 1985 635
28. J.C. Herr T.A. Summers R.S. McGee W.M. Sutherland M. Sigman R.J. Evans Characterization of a monoclonal antibody to a conserved epitope on human seminal vesicle specific peptides: a novel probe/marker system for semen identification Biol. Reprod. 35 1986 773
29. R.J. Evans J.C. Herr Immunohistochemical localization of the MHS-5 antigen in principal cells of human seminal vesicle epithelium Anat. Rec. 214 1986 372
30. R.S. McGee J.C. Herr Human seminal vesicle-specific antigen is a substrate for prostate-specific antigen (or P-30) Biol. Reprod. 39 1988 499
31. K. Akiyama T. Nakamura S. Iwanaga M. Hara The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein FEBS Letters 225 1987 168
32. Y. Ban M.C. Wang K.W.K. Watt R. Loor M. Chu The proteolytic activity of human prostate-specific antigen Biochem. Biophys. Res. Comm. 123 1984 482
33. J.Y. Dubé C. Lazure R.R. Tremblay Dog prostate arginine esterase is related to human prostate specific antigen Clin. Invest. Med. 9 1986 51
34. F. Lee S.T. Torp-Pedersen J.T. Carroll D.B. Siders C. Christensen-Day A.E. Mitchell Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia Urology 34 suppl. 1989 4
35. F. Lee S.T. Torp-Pedersen P.J. Littrup R.D. McLeary T.A. McHugh A.P. Smid P.J. Stella G.S. Borlaza Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen Radiology 170 1989 29
36. F. Lee P.J. Littrup S.T. Torp-Pedersen C. Mettlin T.A. McHugh J.M. Gray G.H. Kumasaka R.D. McLeary Prostate cancer: comparison of transrectal US and digital rectal examination for screening Radiology 168 1988 389
37. T.A. Stamey N. Yang A.R. Hay J.E. McNeal F.S. Freiha E. Redwine Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate New Engl. J. Med. 317 1987 909
38. H.C.B. Graves N. Wehner T.A. Stamey Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard J. Urol. 144 1990 1516
39. T.A. Stamey J.N. Kabalin J.E. McNeal I.M. Johnstone F. Freiha E.A. Redwine N. Yang Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients J. Urol. 141 1989 1076
40. T.A. Stamey J.N. Kabalin Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients J. Urol. 141 1989 1070
41. T.A. Stamey J.N. Kabalin M. Ferrari Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients J. Urol. 141 1989 1084
42. J.N. Kabalin K.K. Hodge J.E. McNeal F.S. Freiha T.A. Stamey Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen J. Urol. 142 1989 326
43. M. Kuriyama M.C. Wang C.L. Lee C.S. Killian L.D. Papsidero H. Inaji R.M. Loor M.F. Lin T. Nishiura N.H. Slack G.P. Murphy T.M. Chu Use of human prostate-specific antigen in monitoring prostate cancer Cancer Res. 41 1981 3874
44. R.S. Yalow S.A. Berson Introduction and general considerations chapt. 1 W.D. Odell W.H. Daughaday Principles of Competitive Protein-binding Assays 1971 J. B. Lippincott Co Philadelphia 1 24
45. N. Yang P.S.A. Pros-Check a double antibody radioimmunoassay for prostate-specific antigen W.J. Catalona D.S. Coffey J.P. Karr Clinical Aspects of Prostate Cancer 1989 Elsevier Science Publishing Co. New York 172 178
46. N. Yang PSA values in BPH and stage A prostate cancer W.J. Catalona D.S. Coffey J.P. Karr Clinical Aspects of Prostate Cancer 1989 Elsevier Science Publishing Co. New York 197 200
47. C.S. Killian N. Yang L.J. Enrich F.P. Vargas M. Kuriyama M.C. Wang N.H. Slack L.D. Papsidero G.P. Murphy T.M. Chu Investigators of the National Prostatic Cancer Project: Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer Cancer Res. 45 1985 886
48. J.E. Oesterling D.W. Chan J.I. Epstein A.W. Kimball Jr. D.J. Bruzek R.C. Rock C.B. Brendler P.C. Walsh Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy J. Urol. 139 1988 766
49. S.W. Dejter Jr. J.S. Martin R.A. McPherson J.H. Lynch Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation Urology 32 1988 288
50. T.J. Maatman The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate J. Urol. 141 1989 1378
51. R.B. Schifman F.R. Ahmann A. Elvick M. Ahmann K. Coulis M.K. Brawer Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared Clin. Chem. 33 1987 2086
52. M.K. Brawer R.B. Schifman F.R. Ahmann M.E. Ahmann K. Coulis The effect of digital rectal examination on serum levels of prostate-specific antigen Arch. Path. Lab. Med. 112 1988 1110
53. H.R. Hughes M.D. Penney P.G. Ryan W.B. Peeling Serum prostatic specific antigen: in vitro stability and the effect of ultrasound rectal examination in vivo Ann. Clin. Biochem. 24 suppl. 1987 206
54. G. Lindstedt A. Jacobsson P.A. Lundberg H. Hedelin S. Pettersson B. Unsgaard Determination of prostate-specific antigen in serum by immunoradiometric assay Clin. Chem. 36 1990 53
55. T.G. Armitage E.H. Cooper W.W. Newling M.R.G. Robinson I. Appleyard The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer Brit. J. Urol. 62 1988 584
56. B. Seamonds N. Yang K. Anderson B. Whitaker L.M. Shaw J.R. Bollinger Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers Urology 28 1986 472
57. J.F. Myrtle P.G. Klimley L.P. Ivor J.F. Brun Clinical utility of prostate-specific antigen (PSA) in the management of prostate cancer Adv. Cancer Diag. 1986 Hybritech, Inc.
58. J.F. Myrtle Normal levels of prostate-specific antigen (PSA) W.J. Catalona D.S. Coffey J.P. Karr Clinical Aspects of Prostate Cancer 1989 Elsevier Science Publishing Co New York 183 189
59. C.J. Ercole P.H. Lange M. Mathisen R.K. Chiou P.K. Reddy R.L. Vessella Prostate specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer J. Urol. 138 1987 1181
60. R.C. Rock D.W. Chan D. Bruzek C. Waldron J.E. Oesterling P.C. Walsh Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen Clin. Chem. 33 1987 2257
61. D.W. Chan D.J. Bruzek J.E. Oesterling R.C. Rock P.C. Walsh Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared Clin. Chem. 33 1987 1916
62. G.L. Hortin R.R. Bahnson M. Daft Κ.-M. Chan W.J. Catalona J.H. Ladenson Differences in values obtained with 2 assays of prostate specific antigen J. Urol. 139 1988 762
63. R.G. Ryall C.J. Story D.R. Turner Reappraisal of the causes of the “hook effect” in two-site immunoradiometric assays Anal. Biochem. 127 1982 308
64. H.C. Vaidya B.A. Wolf N. Garrett W.J. Catalona R.V. dayman M.H. Nahm Extremely high values of prostate-specific antigen in patients with adenocarcinoma of the prostate; demonstration of the “hook effect.” Clin. Chem. 34 1988 2175
65. H. Alfthan U.H. Stenman Falsely low results obtained with the Hybritech Tandem-R PSA assay Clin. Chem. 34 1988 2152
66. G. Boder B.A. Wolf B. Hinds M.H. Nahm M.G. Scott More on “hook effects” in immunometric assays for prostate-specific antigen Clin. Chem. 35 1989 1262
67. R.J. Liedtke J.D. Batjer Measurement of prostate-specific antigen by radioimmunoassay Clin. Chem. 30 1984 649
68. Myrtle, J. F.: Personal communication.
69. A.W. Bruce B.K. Choe Tumor markers in prostatic disease A.W. Bruce J. Trachtenberg Adenocarcinoma of the Prostate 1987 Springer-Verlag New York 196 219
70. M.A. Hudson R.R. Bahnson W.J. Catalona Clinical use of prostate specific antigen in patients with prostate cancer J. Urol. 142 1989 1011
71. M.A. Ferro L. Barnes J.B.M. Roberts P.J.B. Smith Tumour markers in prostatic carcinoma: a comparison of prostate-specific antigen with acid phosphatase Brit. J. Urol. 60 1987 69
72. J.P. Weber J.E. Oesterling C.A. Peters A.W. Partin D.W. Chan P.C. Walsh The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia J. Urol. 141 1989 987
73. A.W. Partin H.B. Carter D.W. Chan J.L. Epstein J.E. Oesterling R.C. Rock J.P. Weber P.C. Walsh Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia J. Urol. 143 1990 747
74. J.E. McNeal D.G. Bostwick Intraductal dysplasia: a premalignant lesion of the prostate Hum. Path. 17 1986 64
75. D.G. Bostwick Prostatic intraepithelial neoplasia (PIN) Urology 34 suppl. 1989 16
76. J.E. McNeal I. Leave J. Alroy E. Skutelsky Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia Amer. J. Clin. Path. 89 1988 41
77. J.E. McNeal J. Alroy L. Leave E.A. Redwine F.S. Freiha T.A. Stamey Immunohistochemical evidence of impaired cell differentiation in the premalignant phase of prostate carcinogenesis Amer. J. Clin. Path. 90 1988 23
78. R. Nagle J. Brawer V. Clarke Immunophenotypic study of prostatic hyperplasia (BPH), dysplasia (PD), and carcinoma (CA) Lab. Invest. 60 1989 65A
79. E.J. Perlmen J.L. Epstein Blood group antigen expression in dysplasia and adenocarcinoma of the prostate Lab. Invest. 60 1989 72A
80. M.K. Brawer Prostatic intraepithelial neoplasia and prostate-specific antigen Urology 34 suppl. 1989 62
81. Brawer, M. K., Rennels, M. A., Nagle, R. B., Schifman, R. A. and Gaines, J. A.: Significance of serum prostate-specific antigen in men undergoing prostate surgery for benign disease. Amer. J. Clin. Path., in press.
82. P.H. Lange C.J. Ercole D.J. Lightner E.E. Fraley R. Vessella The value of serum prostate specific antigen determinations before and after radical prostatectomy J. Urol. 141 1989 873
83. T.M. Chu G.P. Murphy What’s new in tumor markers for prostate cancer? Urology 27 1987 487
84. P.C. Walsh Benign prostatic hyperplasia chapt. 27 P.C. Walsh R.F. Gittes A.D. Perlmutter T.A. Stamey 5th ed. Campbell’s Urology vol. 2 1986 W. B. Saunders Co Philadelphia 1248 1265
85. W.H. Cooner B.R. Mosley C.L. Rutherford Jr. J.H. Beard H.S. Pond W.J. Terry T.C. Igel D.D. Kidd Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen J. Urol. 143 1990 1146
86. M.K. Brawer P.H. Lange Prostate-specific antigen:, its role in early detection, staging, and monitoring of prostatic carcinoma J. Endourol. 3 1989 227
87. F.M. Chybowski J.J. Larson Keller E.J. Bergstralh J.E. Oesterling Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters J. Urol. 145 1991 313
88. E. Silverberg C.C. Boring T.S. Squires Cancer statistics 1990 CA 40 1990 1
89. Zincke, H.: Personal communication.
90. H.B. Carter A.W. Partin J.E. Oesterling J.P. Weber J.L. Epstein D.W. Chan R.C. Rock P.C. Walsh The use of prostate-specific antigen in the management of patients with prostate cancer: The Johns Hopkins experience W.J. Catalona D.S. Coffey J.P. Karr Clinical Aspects of Prostate Cancer 1989 Elsevier Science Publishing Co. New York 247 254
91. W.R. Morgan H. Zincke L.M. Rainwater R.P. Myers G.G. Klee Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation) J. Urol. 145 1991 319
92. D.J. Lightner P.K. Reddy P.H. Lange PSA response to radiation therapy (RT) after radical prostatectomy (RP) J. Urol. 141 part 2 1989 183A
93. T.A. Stamey J.N. Kabalin M. Ferrari N. Yang Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients J. Urol. 141 1989 1088
94. Lightner, D. J., Lange, P. H., Ercole, C. J., Unger, K., Sauers, J. B., Mathisen, M. L. and Vessella, R. L.: Serum prostatic-specific antigen (PSA) and the utility of isotopic bone scan (BOS) in the monitoring of patients with carcinoma of the prostate (CAP). Proc. Amer. Ass. Clin. Oncol., abstract 461, 1988.
95. Bilhartz, D. L., Young, C. Y. F., Flanagan, W. F., He, W. and Tindall, D. J.: Expression of prostate-specific antigen (PSA) in LNCaP cells in culture. Read at Molecular and Cellular Biology of Prostate Cancer Meeting, Prouts Neck, Maine, October 1989.
96. Z. Csapo K. Brand R. Walther K. Fokas Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice J. Urol. 140 1988 1032
97. M.E. Leo D.L. Bilhartz E.J. Bergstralh J.E. Oesterling Prostate-specific antigen in hormonally treated D2 prostate cancer: is it always an accurate indicator of disease status? J. Urol. 145 1991 802
98. B.S. Stein R.O. Petersen S. Vangore A.R. Kendall Immunoperoxidase localization of prostate-specific antigen Amer. J. Surg. Path. 6 1982 553
99. S.E. Vernon W.D. Williams Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostate specific antigen J. Urol. 130 1983 95
100. E.P. Allhoff K.H. Proppe C.M. Chapman C.-W. Lin G.R. Prout Jr. Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer J. Urol. 129 1983 315
101. M. Ghazizadeh S. Kagawa K. Maebayashi K. Izumi K. Kurokawa Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen Urol. Int. 39 1984 9
102. D.M. Purnell B.M. Heatfield B.F. Trump Immunocyto-chemical evaluation of human prostatic carcinomas for carcino-embryonic antigen, nonspecific cross-reacting antigen, B chorionic gonadotrophin, and prostate-specific antigen Cancer Res. 44 1984 285
103. J.I. Epstein J.C. Eggleston Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate Hum. Path. 15 1984 853
104. T.F. Ford D.N. Butcher J.R.W. Masters M.C. Parkingson Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice Brit. J. Urol. 57 1985 50
105. H. Svanholm M. Horder Clinical application of prostatic markers. I. Classification of prostatic tumors using immunohistochemical techniques. Scand J. Urol. Nephrol. 107 suppl. 1988 65
106. M.K. Brawer R.B. Nagle W. Pitta F.S. Freiha S.L. Gamble Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates Cancer 63 1989 454
107. A.C. Jöbsis G.P. de Vries R.R.H. Anholt G.T.B. Sanders Demonstration of the prostatic origin of metastases Cancer 41 1978 1788
108. A.C. Jöbsis G.P. de Vries A.E.F.H. Meijer J.S. Ploem The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry Histochem. J. 13 1981 961
109. C.Y. Li K.W. Lam L.T. Yam Immunohistochemical diagnosis of prostatic cancer with metastasis Cancer 46 1980 706
110. M. Nadji S.Z. Tabei A. Castro T.M. Chu A.R. Morales Prostatic origin of tumors. An immunohistochemical study Amer. J. Clin. Path. 73 1980 735
111. L.H. Sobin B.M. Hjermstad M.C. Maj I.A. Sesterhenn E.B. Helwig Prostatic acid phosphatase activity in carcinoid tumors Cancer 58 1986 136
112. H. Svanholm Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase Acta Path. Microbiol. Immunol. Scand., sect. A 94 1986 7